Holen Sie sich die Stockscreener-App
65.30
0.05%
-0.03
Handel nachbörslich:
65.30
Schlusskurs vom Vortag:
$65.33
Offen:
$64.99
24-Stunden-Volumen:
2.28M
Relative Volume:
0.64
Marktkapitalisierung:
$14.52B
Einnahmen:
$4.03B
Nettoeinkommen (Verlust:
$556.70M
KGV:
27.55
EPS:
2.37
Netto-Cashflow:
$970.10M
1W Leistung:
+1.60%
1M Leistung:
+5.31%
6M Leistung:
-8.98%
1J Leistung:
-11.19%
1-Tages-Spanne:
$64.56
$65.52
1-Wochen-Bereich:
$63.68
$67.00
52-Wochen-Spanne:
$51.90
$84.67
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
65.30 | 14.52B | 4.03B | 556.70M | 970.10M | 2.37 |
|
ISRG
Intuitive Surgical Inc
|
540.60 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.27 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.30 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.88 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.22 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic Joins NEST Governance Committee - Medical Product Outsourcing
From Now to 2032: Unpacking the Bone Mineral Densitometry - openPR.com
Global C-Arms Market Trends & Forecast 2025-2032 | Major - openPR.com
Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Breast Cancer Diagnostics Market OutlookImaging, Biopsy & - openPR.com
Chennai Open added to 2025 Hologic WTA Tour calendar - WTA Tennis
Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence? - Yahoo Finance
Is Hologic (NASDAQ:HOLX) Using Too Much Debt? - simplywall.st
BioZorb Lawsuit LawyerBreast Biopsy Marker RecallJune 2025 Update - Levin Papantonio
Bone Mineral Testing Market Generated Opportunities, Future - openPR.com
Tomosynthesis Market Set to Witness High Growth with Adoption of 3D Breast Imaging | Hologic Inc., GE Healthcare - openPR.com
Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate? - The Globe and Mail
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact? - MSN
Can Hologic Lean On Its Strengths In A Tough Macroeconomic Climate? - Barchart.com
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know - Yahoo Finance
CGH and Hologic ink MoU on breast imaging research and education - MSN
Hologic Climbs 13% In A Month: How Should You Play The Stock? - Barchart.com
Hologic Climbs 13% in a Month: How Should You Play the Stock? - The Globe and Mail
Breast Cancer Diagnostic Market Set to Witness Advances in Imaging and Biomarkers | Hologic, GE Healthcare - openPR.com
Parallel Advisors LLC Has $60,000 Position in Hologic, Inc. (NASDAQ:HOLX) - Defense World
Uterine Fibroid Treatment Devices Market Set to Witness - openPR.com
Histology And Cytology Market Is Booming So Rapidly 2025-2032 - openPR.com
BNP Paribas Exane Adjusts Price Target on Hologic to $73 From $71, Maintains Outperform Rating - MarketScreener
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
BioZorb Lawsuit and Settlement Information: June 2025 - AboutLawsuits.com
Hologic at Jefferies Global Healthcare Conference: Strategic Insights - Investing.com
Hologic at Jefferies Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com UK
Transcript : Hologic, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 11 - MarketScreener
Gynecological Devices Market Set to Witness Significant Growth - openPR.com
Hologic at 45th Annual William Blair Growth Stock Conference: Strategic Focus on Women’s Health By Investing.com - Investing.com South Africa
Hologic at 45th Annual William Blair Growth Stock Conference: Strategic Focus on Women’s Health - Investing.com Australia
Hologic, Inc. (NASDAQ:HOLX) Short Interest Up 35.7% in May - Defense World
Hologic turns down $16 billion buyout offer from TPG and Blackstone - DOTmed
Breast Lesion Localization Methods Market Set to Witness Demand - openPR.com
Bone Densitometers Market Generated Opportunities, Future - openPR.com
Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation - Business Wire
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise
X-ray Machine Manufacturing Market Is Booming Worldwide | - openPR.com
Digital X-ray Devices Market Is Booming So Rapidly 2025-2032Hologic, Inc., Hitachi, Ltd., Siemens Healthineers - openPR.com
Hologic turns down USD 16.7B non-binding offer from TPG, Blackstone - Medical Buyer
Blackstone (NYSE:BX) and TPG Eye US$16 Billion Hologic Buyout in Rejected Offer - simplywall.st
Hologic is reportedly a private equity takeover target - MassDevice
Hologic (HOLX) Surges 23% After Trade Resumption | HOLX Stock Ne - GuruFocus
TPG and Blackstone offer $16bn to take Hologic private in major healthcare bid - Private Equity Insights
Global markets live: Nvidia, General Motors, Hologic, Chevron, Stellantis… - marketscreener.com
Forecasting The Future: 6 Analyst Projections For Hologic - Benzinga
Needham Reiterates Hold Rating for Hologic (HOLX) | HOLX Stock N - GuruFocus
Q1 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hologic Inc-Aktie (HOLX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Option Exercise |
62.60 |
22,902 |
1,433,659 |
52,813 |
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Sale |
76.34 |
24,856 |
1,897,482 |
27,957 |
0.29%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):